Early Testing Matters

Diabetes Testing Centers™ (DTC) helps both new and established medical providers unlock the full clinical and financial potential of early detection screening for diabetes patients. We go beyond routine glucose checks by offering CMS billable assessments and point-of-care reimbursable diagnostics that are faster, more impactful, and fully reimbursable. DTC transforms routine exams—including Annual Wellness Visits—into advanced preventive care encounters by combining reimbursable diagnostics, state-of-the-art early-detection technology, and chronic-care pathways that ensure compliance and payment integrity. 

Note: Each test is based on medical necessity for early detection, requires an average of three minutes or less to administer, and targets the complications most likely to affect patients with diabetes.

Quick Assessment Examples

1. Heart Disease: Cardiovascular disease is the leading cause of death in the United States, responsible for approximately 1 in every 5 deaths (Center for Disease Control & Prevention). For individuals with diabetes, the risk is up to 4 times higher than for those without diabetes, with earlier onset, faster progression, and higher mortality.

2. Diabetic Peripheral Neuropathy (DPN): Studies estimate that up to 50% of patients with diabetes will develop some form of neuropathy during their lifetime. Small-fiber damage is often the first, years before large-fiber involvement and can precede other microvascular complications like retinopathy and nephropathy (American Diabetes Association, Diabetes Care). 

3. Cognitive Dysfunction: Alzheimer’s disease is fatal because it progressively damages the brain’s ability to control vital functions such as swallowing, breathing, and heart regulation, ultimately leading to death. Neurological impairment is recognized as a diabetes complication, with evidence suggesting cognitive decline occur simultaneously with neuropathy. (Kodl & Seaquist, Nature Reviews Endocrinology).

4. Psychological Disorders: Depression and anxiety are highly prevalent in patients with painful diabetic neuropathy. Published studies in Diabetes Care, Pain, and the Journal of Neurology, Neurosurgery & Psychiatry report rates as high as 60%. These comorbidities complicate self-management, worsen outcomes, and increase overall healthcare utilization.

Our exclusive 25 turnkey Diabetes & Chronic Care Programs® are designed for primary care and multispecialty settings and chronic patients. Built on the same protocols and equipment trusted by national specialty centers, each compact program can operate in a single room and deliver CMS reimbursement-ready programs—many of which do not require new staff, new construction, or disruption to your workflow.

By partnering with DTC, providers can screen smarter, intervene earlier, and transform routine checkups into life-saving opportunities—while building sustainable new revenue streams that strengthen their practice long-term.

Reduced Workflows. Better Diagnostics.

Reimbursable diagnostics

Most diabetic and chronic patients don't always see the specialists who could detect early complications because referrals are delayed, so the urgency is slowed and the disease progresses silently. The difference isn’t necessarily the visit itself—it’s the results of the diagnostic tools that  help determine the plan of care for the patients. Traditional screening tools in PCP clinics are often outdated, limited in what they detect and non-reimbursable (e.g. monofilaments). DTC brings modern, clinically validated, reimbursable diagnostics into a practice, enabling primary care and multispecialty clinics to identify risks earlier and keep care in-house—before referrals are needed. Better detection. Better outcomes. Better Revenue. 

Our Diabetes & Chronic Care Programs® give providers a simple yet powerful way to intervene at this gateway. Through CMS billable assessments, reimbursable diagnostics, and early detection screenings, we help close care gaps while building new revenue streams. Instead of relying on outdated tools (e.g., fishing string for foot exams), replace them with modern, non-invasive diagnostic devices that are reimbursable and fit directly into existing workflows. The visit stays the same—the tools simply get better, the data becomes clearer, and the clinic is reimbursed for the care it is already providing. 

Nearly 80% of people with diabetes will develop one or more complications over time, while only a small minority remain unaffected. Most patients are silently progressing toward cardiovascular disease, kidney damage, retinopathy, and preventable amputations. By the time many of these are discovered, the damage is often advanced, requiring costly specialist care and creating long-term burdens for patients and payers alike.

Our turnkey programs make it possible to intervene earlier with rapid, non-invasive, point-of-care tools such as neuropathy testing, PAD screening, cognitive assessments, and cardiovascular risk evaluations. Each fits seamlessly into your workflow, enabling your team to detect risks, initiate treatment plans, and manage progression both in-clinic and remotely. The result is better outcomes for patients, stronger trust in your care, and new reimbursable revenue streams that support practice growth.

• Primary Care

• Neurology

• Cardiology & Vascular

• Endocrinology & Metabolism

• Podiatry & Wound Care

• Functional & Regenerative*

Why Offer In-House Specialty Testing

Most diabetic patients never see the specialists who could detect early complications—referrals are delayed, visits are missed, and disease progresses silently. Primary care and multispecialty clinics are best positioned to catch problems early with in-office testing. Diabetes Testing Centers™ (DTC) makes this easy by integrating into one exam room and providing up to 25 reimbursable assessments for neuropathy, vascular, cognitive, metabolic risks, and more. This turnkey model helps clinics improve outcomes, retain revenue, and deliver specialty-level care where patients already are. 

Upgrade to Reimbursable Tools